The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-stakeholder platform to prospectively link longitudinal real-world clinico-genomic, imaging, and outcomes data for patients with metastatic lung cancer.
 
Michael W Lu
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Guneet Walia
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Katja Schulze
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Michelle Yuri Doral
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Sophia L. Maund
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Sarah Gaffey
Employment - Foundation Medicine
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
Moran N Cabili
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Ariel B. Bourla
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health; Roche Pharma AG
 
Robert J. Green
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health; Roche
Other Relationship - Flatiron Health
 
Eric C. Santos
Employment - Cancer and Hematology Centers of Western Michigan
Leadership - Cancer and Hematology Centers of Western Michigan
Stock and Other Ownership Interests - Cancer and Hematology Centers of Western Michigan
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - Flatiron Health (Inst); Sanofi (Inst)
 
Roy S. Herbst
Leadership - Junshi Pharmaceuticals
Consulting or Advisory Role - Abbvie; ARMO Biosciences; AstraZeneca; Biodesix; Bolt Biotherapeutics; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Genmab; Halozyme; Heat Biologics; I-Mab; Immunocore; Infinity Pharmaceuticals; Junshi Pharmaceuticals; Lilly; Loxo; Merck; Midas Health Analytics; Mirati Therapeutics; Nektar; Neon Therapeutics; NextCure; Novartis; Pfizer; Sanofi; Seagen; Shire; Spectrum Pharmaceuticals; Symphogen; Takeda; TESARO; Tocagen
Research Funding - AstraZeneca; Genentech/Roche; Lilly; Merck
 
Anne C. Chiang
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Genentech/Roche
Research Funding - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Millennium; OncoMed; Onyx; Stem CentRx
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Genentech/Roche
 
Lee S. Schwartzberg
Stock and Other Ownership Interests - Vector Oncology
Honoraria - Amgen; AstraZeneca; E.R. Squibb Sons, LLC; Genentech; Genomic Health; Helsinn Healthcare; Myriad Genetics; NanoString Technologies; Napo Pharmaceuticals; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Athenex; Biocept; bioTheranostics; Bristol-Myers Squibb; Caris Life Sciences; Coherus Biosciences; E.R. Squibb Sons, LLC; Genentech; Genomic Health; Helsinn Therapeutics; Lilly; Merck; Novartis; Pfizer; Roche; Spectrum Pharmaceuticals; Tesaro
Speakers' Bureau - Coherus Biosciences; Puma Biotechnology
Research Funding - Amgen (Inst); Bayer Health (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics; MedImmune (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Tesaro (Inst)